The Maryland Psychiatric Research Center scale and the characterization of involuntary movements

Psychiatry Research

Volumn 70, Issue 1, 1997, Pages 21-37

  Cassady, Shawn L ^a   Thaker, Gunvant K ^a   Summerfelt, Ann ^a   Tamminga, Carol A ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Diagnosis; Movement disorder; Prevalence; Reliability; Tardive dyskinesia; Validity

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DYSKINESIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HOSPITAL; PARKINSONISM; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; TARDIVE DYSKINESIA;

DYSKINESIA, DRUG-INDUCED; HUMANS; MARYLAND; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0030983292     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(97)03031-X     Document Type: Article

References (59)

1. Armitage, P. and Berry, G. (1987) Statistical Methods in Medical Research. Blackwell Scientific Publications, Oxford, p. 473.
2. Beck, A.T., Brown, G., Berchick, R.J., Stewart, B.L. and Steer, R.A. (1990) Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatients. Am J Psychiatry 147, 190-195.
3. Bell, R.C.H. and Smith, R.C. (1978) Tardive dyskinesia: characterization and prevalence in a statewide system. J Clin Psychiatry 39, 39-42, 46-47.
4. Casey, D.E. and Hansen, T.E. (1984) Spontaneous dyskinesias. In: Jeste, D.V. and Wyatt, R.J. (Eds.), Neuropsychiatric Movement Disorders. American Psychiatric Press, Washington, DC, pp. 68-95.
5. Cassady, S.L., Thaker, G.K., Moran, M., Birt, A. and Tamminga, C.A. (1992) The GABA agonist-induced changes in motor, oculomotor and attention measures correlate in schizophrenics with tardive dyskinesia. Biol Psychiatry 32, 302-311.
6. Cassady, S., Thaker, G., Moran, M., Gerbaldo, H. and Summerfelt, A. (1991)The search for subsyndromes in tardive dyskinesia. Presented at the International Congress on Schizophrenia Research, Tucson, Arizona.
7. Cassady, S., Thaker, G.K., Moran, M., Nguyen, J. and Tamminga, C. (1990) Tardive dyskinesia longitudinal follow-up study [abstract]. Biol Psychiatry 27, 130.
8. Cassady, S.L., Thaker, G.K. and Tamminga, C.A. (1993) Pharmacologic relationship of antisaccade and dyskinesia in schizophrenic patients. Psychopharmacol Bull 29, 235-240.
9. Cassady, S.L., Thaker, G.K. and Tamminga, C.A. (1997) GABAergic treatments in tardive dyskinesia. In: Yassa, R., Nair, N.P.V. and Jeste, D.V (Eds.), Neuroleptic-Induced Movement Disorders. Cambridge University Press, London, pp. 753-784.
10. Chouinard, G., Ross-Chouinard, A., Annable, L. and Jones, B.D. (1980) Extrapyramidal symptom rating scale. J Can Sci Neurol 7, 233.
11. Crane, G.E. and Najanjo, E.R. (1974) Motor disorders induced by neuroleptics. Arch Gen Psychiatry 24, 179-184.
12. Crane, G.E., Ruiz, P. and Kernohan, W.J. (1969) Effects of drug withdrawal on tardive dyskinesia. Act Nerv Super 11, 30-35.
13. Dixon, L., Thaker, G., Conley, R., Ross, D., Cascella, N. and Tamminga, C. (1993) Changes in psychopathology and dyskinesia after neuroleptic withdrawal in a double-blind design. Schizophr Res 10, 267-271.
14. Gardos, G. and Cole, J.O. (1980) Problems in the assessment of tardive dyskinesia. In: Fann, W.E., Smith, R.C., Davis, J.M. and Domino, E.F. (Eds.) Tardive Dyskinesia and Other Drug-Induced Movement Disorders Spectrum, New York, pp. 201-215.
15. Gardos, G., Cole, J.O. and LaBrie, R. (1977) The assessment of tardive dyskinesia. Arch Gen Psychiatry 34, 1206-1212.
16. Gerbaldo, H., Nguyen, J.A., Thaker, G.K., Moran, M.J. and Tamminga, C.A. (1990) Decrease in tardive dyskinesia with progabide, a mixed GABA agonist [abstract]. Biol Psychiatry 27, 131.
17. Gerlach, J., Korsgaard, S., Clemmesen, P., Lund Lauersen, A-M., Magelund, G., Noring, U., Povlsen, U.J., Bech, P. and Casey, D.E. (1993) The St. Hans rating scale for extrapyramidal syndromes: reliability and validity. Acta Psychiatr Scand 87, 244-252.
18. Glazer, W.M., Morganstern, H., Niedzwieki, D. and Hughes, J. (1988) Heterogeneity of tardive dyskinesia, a multivariate analysis. Br J Psychiatry 152, 253-259.
19. Golden, R.R. (1987) A taxometric method for diagnosis of tardive dyskinesia. J Psychiatr Res 21, 233-241.
20. Guy, W. (1976) ECDEU Assessment Manual for Psychopharmacology, US Dept Health, Education and Welfare Publication (ADM) 76-338, National Institute of Mental Health, Rockville, MD.
21. Hikosaka, O. and Wurtz, R.H. (1985) Modification of saccadic eye movements by GABA-related substances. I. Effects of muscimol and bicuculline in monkey superior colliculus. II. Effect of muscimol in monkey substantia pars reticulata. J. Neurophysiol 53, 266-308.
22. Hobi, V., Gilsdorf, U., Kocher, R. and Fleischhauer, J. (1986) Ein fremdrating zur erfassung von dyskinesien. Schweiz Arch Neurol Neurochir Psychiatr 137, 79-91.
23. Hsiao, J.K., Bartko, J.J. and Potter, W.Z. (1989) Diagnosing diagnoses. Arch Gen Psychiatry 46, 664-667.
24. Hyde, T.M., Hotson, J.R. and Kleinman, J.E. (1991) Differential diagnosis of choreiform tardive dyskinesia. J Neuropsychiatry 3, 255-268.
25. Kane, J.M. and Smith, J.M. (1982) Tardive dyskinesia, prevalence and risk factors, 1959-1979. Arch Gen Psychiatry 39, 473-481.
26. Kidger, T., Barnes, T.R.E., Trauer, T. and Taylor, P.J. (1980) Sub-syndromes of tardive dyskinesia. Psychol Med 10, 513-520.
27. Kocher, R., Fleischhauer, J., Hobi, V. and Gilsdorf, U. (1986) Dyskinesien in einer klinischen population: ergebnisse einer nachuntersuchung im vergleich. Schweiz Arch Neurol Neurochir Psychiatr 137, 63-78.
28. Lahti, A., Thaker, G.K., Nguyen, J.A. and Tamminga, C.A. (1988) Reversibility of tardive dyskinesia following neuroleptic withdrawal. Soc Neurosci Abstr 14, 1241.
29. Lohr, J.B., Wisniewski, A. and Jeste, D.V. (1986) Neurological aspects of tardive dyskinesia. In: Nasrallah, H.A. and Weinberger, D.R. (Eds.), Handbook of Schizophrenia, Volume 1: The Neurology of Schizophrenia. Elsevier Science Publishers, pp. 97-119.
30. Marsden, C.D., Mindham, R.H.S. and Mackay, A.V.P. (1986) Extrapyramidal movement disorders produced by antipsychotic drugs. In: Bradley, P.B. and Hirsch, S.R. (Eds.), The Psychopharmacology and Treatment of Schizophrenia. Oxford University Press, Oxford, pp. 340-402.
31. Miller, L.G. and Jankovic, J. (1990) Neurologic approach to movement disorders: a study of 125 patients. South Med J 83, 525-532.
32. Morganstern, H. and Glazer, W.M. (1993) Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Arch Gen Psychiatry 59, 723-733.
33. Morley, S. and Snaith, P. (1989) Principles of psychological assessment. In: Freeman, C. and Tyrer, P. (Eds.), Research Methods in Psychiatry, A Beginner's Guide Gaskell, The Royal College of Psychiatrists, London, pp. 133-147.
34. Mossman, D. and Somoza, E. (1989) Maximizing diagnostic information from the dexamethasone suppression test -an approach to criterion selection using receiver operating characteristic analysis. Arch Gen Psychiatry 46, 653-660.
35. Owens, D.G., Johnstone, E.C. and Frith, C.D. (1982) Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics. Arch Gen Psychiatry 39, 452-461.
36. Penny, J.B. and Young, A.B. (1993) Huntington's Disease. In: Jankovic, J. and Tolosa, E. (Eds.), Parkinson's Disease and Movement Disorders Williams and Wilkins, Baltimore, pp. 205-216.
37. Rao, J.M., Cowie, V.A. and Mathew, B. (1987) Tardive dyskinesia in neuroleptic medicated mentally handicapped subjects. Acta Psychiatr Scand 76, 507-513.
38. Schönecker, M. (1957) Ein eigentumliches syndrom im oralen bereich bei megaphen applikation. Nervenarzt 28, 35-36.
39. Schooler, N.R. (1988) Evaluation of drug-related movement disorders in the aged. Psychopharmacol Bull 24, 603-607.
40. Schooler, N.R. and Kane, J.M. (1982) Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 39, 486-487.
41. Severe, J.B. and Creecy, R.H. (1984) Modular algorithm for tardive dyskinesia diagnosis (maltd). J Psychiatr Res 18, 245-253.
42. Sigwald, J., Boutier, D. and Courvoisier, S. (1959) Les accidents neurologiques des medications neuroleptiques. Rev Neurol 100, 553-595.
43. Simpson, G.M., Lee, J.H., Zoubok, B. and Gardos, G. (1979) A rating scale for tardive dyskinesia. Psychopharmacology 64, 171-179.
44. Simpson, G.M. and Singh, H. (1988) Tardive dyskinesia rating scales. Encephale 14, 175-182.
45. Smith, J.M., Kucharski, L.T., Eblen, C., Knutsen, E. and Linn, C. (1979a) An assessment of tardive dyskinesia in schizophrenic outpatients. Psychopharmacology 64, 99-104.
46. Smith, J.M., Kucharski, L.T., Oswald, W.T. and Waterman, L.J. (1979b) A systematic investigation of tardive dyskinesia in inpatients. Am J Psychiatry 136, 918-922.
47. Smith, R.C., Klass, D. and Davis, J.M. (1980) The Smith tardive dyskinesia scale. In: Fann, W.E., Smith, R.C., Davis, J.M. and Domino, E.F. (Eds.), Tardive Dyskinesia and Other Drug-Induced Movement Disorders Spectrum, New York, pp. 243-267.
48. Sprague, R.L. and Kalachnik, J.E. (1991) Reliability, validity, and a total score cut-off for the dyskinesia identification system: condensed user scale (discus) with mentally ill and mentally retarded populations. Psychopharmacol Bull 27, 51-58.
49. Sprague, R.L., Kalachnik, J.E. and Shaw, K.M. (1989) Psychometric properties of the dyskinesia identification system: condensed user scale (discus). Ment Retard 27, 141-148.
50. Tamminga, C.A., Thaker, G.K., Moran, M., Kakigi, T. and Gao, X-M. (1994) Clozapine in tardive dyskinesia: observations from human and animal model studies. J Clin Psychiatry 55 (suppl B), 102-106.
51. Tamminga, C.A., Thaker, G.K. and Nguyen, J.A. (1989) GABAmimetic treatments for tardive dyskinesia: efficacy and mechanism. Psychopharmacol Bull 25, 43-46.
52. Thaker, G.K., Ferraro, T.N., Hare, T.A. and Tamminga, C.A. (1988) Pathophysiology and therapy of tardive dyskinesia: the GABA connection. In: Wolf, M.E. (Ed.), Tardive Dyskinesia: Biologcal Mechanisms and Clinical Aspects. American Psychiatric Press, Washington, D.C., pp. 197-216.
53. Thaker, G.K., Nguyen, J.A., Strauss, M.E., Jacobson, R., Kaup, B.A. and Tamminga, C.A. (1990) Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy. Am J Psychiatry 147, 445-451.
54. Thaker, G., Kirkpatrick, B., Buchanan, R.W., Ellsberry, R., Lahti, A. and Tamminga, C. (1989a) Oculomotor abnormalities and their clinical correlates in schizophrenia. Psychopharmacol Bull 25, 491-497.
55. Thaker, G.K., Nguyen, J.A. and Tamminga, C.A. (1989b) Saccadic distractibility in schizophrenic patients with tardive dyskinesia. Arch Gen Psychiatry 46, 755-756.
56. Thaker, G.K., Nguyen, J.A. and Tamminga, C.A. (1989c) Increased saccadic distractibility in tardive dyskinesia: functional evidence for subcortical GABA dysfunction. Biol Psychiatry 25, 49-59.
57. Thaker, G.K., Tamminga, C.A., Alphs, L.D., Lafferman, J., Ferraro, T.N. and Hare, T.A. (1987) Brain gamma-aminobutyric acid abnormality in tardive dyskinesia. Arch Gen Psychiatry 44, 522-529.
58. Uhrbrand, L. and Faurbye, A. (1960) Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine and electroconvulsive therapy. Psychopharmacology 1, 408-418.
59. Youden, W.J. (1950) Index for rating diagnostic tests. Cancer 3, 32-35.